Executive Summary
This report compares what is currently published in the RegDesk backend (Elasticsearch / MCP layer) against the official Algerian regulatory requirements for IVD medical devices, as governed by Health Law No. 18-11 (2018), Executive Decree No. 20-324 (2020), and Executive Decree No. 23-101 (2023). The main regulatory authority is the ANPP (Agence Nationale des Produits Pharmaceutiques).
The analysis covers four regulatory tile areas: CE Marking, Packaging & Labeling, IVD Classification, and Post-Market Surveillance. Several significant gaps were identified — primarily missing tile content and an emerging UDI mandate not yet reflected in the backend.
7
Total Gaps Found
3
Partial Coverage
1
Confirmed Present
1
New Requirement (UDI 2027)
⚠️ Backend Data Status: The RegDesk Elasticsearch indices (application_stats_index, ccp_stats_index, ccp-reports) do not contain granular regulatory tile content for Algeria. The MCP layer currently returns only country metadata, agencies, and classification system identifiers — not CommonRegulations or Obligations tile content. All gaps below reflect the delta between what the MCP/backend currently serves and what the official regulations require.
Tile 1 — CE Marking
Governing reference: Health Law No. 18-11 (Art. 212–213); Executive Decree No. 20-324 (2020); ANPP Registration Guidelines
| Requirement | Official Regulation Says | Backend Currently Shows | Status |
|---|---|---|---|
| CE Marking as prerequisite | CE Certificate (EU Notified Body) is not legally mandatory but is a highly preferred supporting document that expedites ANPP review. FDA Certificate or FSC from country of origin are accepted equivalents. | Not populated — tile content absent | GAP |
| Accepted international certifications | CE Certificate, FDA 510(k)/PMA clearance, or Free Sale Certificate (FSC) from country of origin — all accepted as part of the homologation dossier. | Not populated | GAP |
| Streamlined review for CE-marked devices | Devices with valid CE marking benefit from accelerated ANPP review vs. non-CE-marked devices. Explicit benefit not quantified in regulation but confirmed by ANPP practice. | Not populated | GAP |
| EC Declaration of Conformity required | Required as part of the technical dossier submission, alongside CE Certificate. | Not populated | GAP |
| ISO 13485 required alongside CE | ISO 13485 certificate (or equivalent QMS certification) is a mandatory submission document regardless of CE status. | Not populated | GAP |
Tile 2 — Packaging & Labeling
Governing reference: Executive Decree No. 20-324 (2020); ANPP Labeling Guidelines; GS1 UDI Mandate (effective 2027)
| Requirement | Official Regulation Says | Backend Currently Shows | Status |
|---|---|---|---|
| Mandatory languages on label | Arabic + French are both strictly required for all labeling and IFUs (Instructions for Use) for consumer/non-professional-use devices. Professional-use devices may accept English + French, but Arabic is strongly preferred. | Not populated | GAP |
| IFU language requirements | For non-professional devices: Arabic and French mandatory. Scientific/technical dossier documents: French required (English accepted only with certified translation). | Not populated | GAP |
| Label consistency with registration dossier | Product names, model references, manufacturer details, and local agent details on label must be identical to those in the registration certificate. Any inconsistency causes review delays or rejection. | Not populated | GAP |
| Change notification for label modifications | Any changes to approved labeling or packaging must be promptly notified to ANPP. Substantive changes may require re-homologation. | Not populated | GAP |
| GS1 UDI / Serialization mandate NEW 2027 | GS1 serialization mandate requiring unique device identification (UDI) and full traceability comes into effect January 1, 2027. All IVD packaging must include GS1-compliant barcodes. | Not populated — emerging requirement not reflected | MISSING — New Req. |
Tile 3 — IVD Classification System
Governing reference: Health Law No. 18-11 (Art. 212–213); aligned with EU IVDR risk classification
| Requirement | Official Regulation Says | Backend Currently Shows | Status |
|---|---|---|---|
| 4-class risk-based system | IVDs classified as Class A (low risk) to Class D (high risk), aligned with WHO and EU classification frameworks. Class determines level of ANPP scrutiny and documentation required. | Classification system identifier present (metadata level only) | PARTIAL |
| Class-specific documentation requirements | Higher-class IVDs (C, D) require clinical performance data and additional scrutiny. Class A may have simplified pathway. Specific requirements per class not yet codified in public-facing ANPP guidance. | Not populated — class-specific tile content absent | PARTIAL |
Tile 4 — Post-Market Surveillance & Registration Process
| Requirement | Official Regulation Says | Backend Currently Shows | Status |
|---|---|---|---|
| Local Authorized Representative required | All foreign manufacturers must appoint a local authorized representative (Registration Certificate Operator — RCO) to manage ANPP submissions and act as official liaison. | Agency (ANPP) identified in metadata | PARTIAL |
| Adverse event reporting | Mandatory PMS including reporting of adverse events, device malfunctions, and incidents posing patient safety risk. Aligned with EU vigilance guidelines. | Not populated | GAP |
| E-TASJIL digital submission platform | ANPP's official registration is managed via the E-TASJIL platform. Physical submission requires a prior online appointment booked through this portal. | Not populated | GAP |
| Transitional provisions (Decree 23-101) | Executive Decree No. 23-101 (March 5, 2023) introduced transitional provisions for devices already on the Algerian market without a homologation decision — grace periods and compliance pathways defined. | Not populated | GAP |
Gap Summary
| Tile | Total Items Checked | Gaps | Partial | OK | Priority |
|---|---|---|---|---|---|
| CE Marking | 5 | 5 gaps | 0 | 0 | 🔴 High |
| Packaging & Labeling | 5 | 4 gaps + 1 new req. | 0 | 0 | 🔴 High |
| IVD Classification | 2 | 0 | 2 partial | 0 | 🟡 Medium |
| Post-Market Surveillance & Registration | 4 | 3 gaps | 1 partial | 0 | 🔴 High |
| TOTAL | 16 | 12 gaps / new reqs. | 3 partial | 0 | — |
Recommended Actions
| # | Action | Tile | Priority |
|---|---|---|---|
| 1 | Populate CE Marking tile with Algeria-specific position: CE marking not legally mandatory but expedites homologation; FDA/FSC accepted equivalents; EC Declaration of Conformity required in dossier. | CE Marking | 🔴 High |
| 2 | Add Packaging/Labeling tile: Arabic + French mandatory for consumer IVD labels and IFUs; consistency between label and registration certificate enforced by ANPP. | Packaging & Labeling | 🔴 High |
| 3 | Add GS1 UDI / Serialization mandate flagged as "Coming into force January 1, 2027" — action required for all IVD manufacturers targeting Algeria market. | Packaging & Labeling | 🔴 High (time-sensitive) |
| 4 | Add E-TASJIL platform reference and local RCO requirement to Registration tile. | Registration Process | 🔴 High |
| 5 | Document transitional provisions under Decree 23-101 (2023) for devices already on market without homologation. | Post-Market Surveillance | 🟡 Medium |
| 6 | Expand IVD Classification tile with class-specific documentation requirements (Class A–D) and link to ANPP technical guidance. | IVD Classification | 🟡 Medium |
Sources
| Source | Type | Reference |
|---|---|---|
| Health Law No. 18-11 (July 2, 2018) | Primary legislation | Algeria — Art. 212–213 (definition of medical devices and IVDs) |
| Executive Decree No. 20-324 (November 22, 2020) | Implementing decree | Homologation procedures for medical devices in Algeria |
| Executive Decree No. 23-101 (March 5, 2023) | Implementing decree | Transitional provisions for devices on market without homologation |
| ANPP — Agence Nationale des Produits Pharmaceutiques | Regulatory authority | anpp.dz/en/ |
| Ethiobiomedical.com — IVD Registration in Algeria (2026) | Industry analysis | ethiobiomedical.com |
| MedDeviceGuide — North Africa Registration Guide | Industry analysis | meddeviceguide.com |
| RegDesk Elasticsearch Backend | Internal backend | Indices: application_stats_index, ccp_stats_index, ccp-reports — Algeria tile content not populated |